FRA:PFE - Deutsche Boerse Ag - US7170811035 - Common Stock - Currency: EUR
Taking everything into account, PFE scores 5 out of 10 in our fundamental rating. PFE was compared to 53 industry peers in the Pharmaceuticals industry. PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PFE is valued quite cheap, while showing a decent growth score. This is a good combination!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROIC | 6.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Altman-Z | 2.14 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.7 | ||
Fwd PE | 7.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.53 | ||
EV/EBITDA | 7.08 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.84% |
FRA:PFE (7/25/2025, 7:00:00 PM)
21.09
-0.48 (-2.25%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 6.84% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.7 | ||
Fwd PE | 7.91 | ||
P/S | 2.25 | ||
P/FCF | 12.53 | ||
P/OCF | 10.05 | ||
P/B | 1.56 | ||
P/tB | N/A | ||
EV/EBITDA | 7.08 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROCE | 9.87% | ||
ROIC | 6.92% | ||
ROICexc | 7.7% | ||
ROICexgc | 36.63% | ||
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% | ||
FCFM | 17.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Debt/EBITDA | 2.45 | ||
Cap/Depr | 40.16% | ||
Cap/Sales | 4.43% | ||
Interest Coverage | 5.35 | ||
Cash Conversion | 58.69% | ||
Profit Quality | 142.33% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 | ||
Altman-Z | 2.14 |